| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 3,682 | 2,779 | 4,371 | 3,860 | 4,387 | 2,987 | 4,650 | 3,476 | 3,361 | 3,331 | 5,189 | 3,636 | 3,382 | 3,371 | 5,848 | 3,768 | 3,672 | 3,153 | 5,698 | 4,114 | 4,261 | 4,160 | 5,851 | 4,695 | 3,929 | 4,414 | 7,005 | 6,571 | 5,756 | 7,251 | 11,356 | 9,855 | 6,865 | 7,015 | 9,210 | 7,811 | 5,680 | 6,807 | 9,400 | 8,838 |
| Expenses | 3,381 | 2,824 | 4,091 | 3,626 | 3,988 | 2,804 | 4,161 | 3,047 | 2,954 | 3,135 | 4,525 | 3,296 | 3,127 | 3,288 | 5,255 | 3,395 | 3,185 | 2,966 | 5,017 | 3,605 | 3,622 | 3,712 | 4,961 | 4,234 | 3,621 | 3,920 | 6,233 | 5,929 | 5,050 | 6,453 | 10,378 | 9,013 | 6,245 | 6,363 | 8,006 | 7,358 | 5,098 | 6,279 | 8,372 | 8,027 |
| EBITDA | 301 | -46 | 280 | 234 | 400 | 184 | 489 | 429 | 407 | 196 | 664 | 340 | 255 | 83 | 592 | 372 | 487 | 187 | 681 | 509 | 639 | 448 | 890 | 461 | 307 | 494 | 772 | 642 | 707 | 798 | 978 | 843 | 620 | 653 | 1,204 | 453 | 582 | 528 | 1,028 | 811 |
| Operating Profit % | 7 % | -2 % | 5 % | 4 % | 8 % | 5 % | 10 % | 12 % | 11 % | 5 % | 12 % | 7 % | 8 % | 2 % | 10 % | 9 % | 13 % | 5 % | 12 % | 12 % | 15 % | 10 % | 15 % | 10 % | 7 % | 10 % | 11 % | 9 % | 11 % | 10 % | 8 % | 9 % | 9 % | 9 % | 12 % | 5 % | 8 % | 7 % | 10 % | 8 % |
| Depreciation | 63 | 62 | 64 | 61 | 63 | 60 | 62 | 63 | 63 | 61 | 62 | 62 | 66 | 63 | 64 | 66 | 79 | 69 | 81 | 82 | 87 | 84 | 84 | 83 | 81 | 81 | 82 | 84 | 88 | 88 | 92 | 92 | 105 | 94 | 101 | 112 | 113 | 117 | 123 | 131 |
| Interest | 92 | 122 | 106 | 106 | 117 | 117 | 109 | 101 | 91 | 85 | 81 | 78 | 91 | 110 | 110 | 93 | 112 | 129 | 115 | 90 | 96 | 89 | 59 | 48 | 40 | 34 | 42 | 38 | 38 | 45 | 79 | 87 | 87 | 82 | 74 | 53 | 86 | 84 | 94 | 99 |
| Profit Before Tax | 191 | -181 | 130 | 79 | 279 | 26 | 337 | 239 | 318 | 50 | 521 | 200 | 98 | -90 | 418 | 213 | 296 | -11 | 484 | 337 | 456 | 276 | 748 | 330 | 186 | 379 | 648 | 521 | 581 | 665 | 807 | 664 | 428 | 477 | 1,029 | 288 | 382 | 327 | 811 | 582 |
| Tax | 22 | 6 | 71 | 42 | 25 | 7 | 127 | 60 | 18 | 29 | 172 | 92 | 58 | 70 | 168 | 68 | 94 | -8 | 104 | 76 | 206 | 145 | 185 | 85 | 124 | 99 | 178 | 126 | 152 | 171 | 242 | 182 | 141 | 152 | 247 | 71 | 88 | 102 | 219 | 166 |
| Net Profit | 168 | -187 | 59 | 37 | 253 | 19 | 210 | 179 | 300 | 20 | 349 | 108 | 41 | -160 | 250 | 145 | 202 | -3 | 380 | 261 | 250 | 130 | 563 | 245 | 62 | 280 | 470 | 395 | 429 | 494 | 565 | 482 | 287 | 325 | 782 | 217 | 294 | 226 | 592 | 416 |
| EPS in ₹ | 7.82 | -10.97 | -0.23 | 0.34 | 11.41 | 0.86 | 7.17 | 7.50 | 13.91 | -0.53 | 12.08 | 2.26 | 0.65 | -11.02 | 5.99 | 4.77 | 8.93 | -1.56 | 10.25 | 8.86 | 8.88 | 1.66 | 17.95 | 6.02 | -0.36 | 7.49 | 13.77 | 12.85 | 17.06 | 15.57 | 13.60 | 14.14 | 10.08 | 6.13 | 25.48 | 6.66 | 12.41 | 5.14 | 17.22 | 10.97 |
EID Parry
780.85
+27.80
(3.69%)
Market Cap
13,881.82 Cr
EPS
50.68
PE Ratio
16.49
Dividend Yield
0.53 %
Industry
Chemicals52 Week High
997.00
52 Week Low
592.80
PB Ratio
1.80
Debt to Equity
0.26
Sector
Fertilizers
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
2,060.00 | #1 60,692.14 | 35.87 | 22,289.80 | -25.20 | #1 1,641 | 122.67 | 62.96 | |
624.65 | 40,419.35 | 461.78 | 5,258.00 | -16.98 | 146 | -73.60 | 43.32 | |
645.25 | 25,852.09 | 15.81 | 18,215.50 | -34.81 | 1,276 | 16.33 | 66.78 | |
780.85 | #4 13,881.82 | #5 16.49 | #1 29,716.90 | #3 -15.78 | #2 1,618 | #4 91.96 | 55.83 | |
119.91 | 9,775.18 | 22.99 | 11,644.00 | -13.31 | 100 | 45.82 | 64.04 | |
175.62 | 6,998.06 | #1 12.63 | 9,531.50 | -17.24 | 564 | 13.47 | 46.29 | |
124.90 | 6,890.58 | 26.18 | 17,146.70 | -20.60 | 225 | 616.07 | 48.48 | |
78.28 | 3,840.25 | 14.50 | 23,659.80 | -20.54 | 150 | -69.65 | 43.28 | |
265.50 | 2,326.50 | 50.12 | 827.90 | -16.14 | 25 | #1 1,276.92 | 42.78 | |
188.72 | 2,236.62 | 16.14 | 3,836.70 | #1 4.48 | 155 | 73.94 | 71.32 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-15.78 %
Net Income Growth
-11.50 %
Cash Flow Change
450.08 %
ROE
-24.69 %
ROCE
-26.83 %
EBITDA Margin (Avg.)
7.21 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 12,899 | 14,166 | 13,431 | 14,599 | 15,990 | 15,024 | 13,264 | 15,943 | 18,779 | 21,493 |
| Fixed Assets | 3,477 | 3,380 | 3,297 | 3,197 | 3,077 | 3,858 | 3,583 | 3,763 | 3,889 | 4,896 |
| Current Assets | 8,738 | 9,950 | 9,460 | 10,672 | 12,003 | 10,448 | 8,873 | 10,839 | 12,593 | 15,194 |
| Capital Work in Progress | 75 | 77 | 39 | 54 | 203 | 85 | 206 | 160 | 486 | 521 |
| Investments | 11 | 651 | 569 | 430 | 418 | 413 | 453 | 563 | 609 | 1,275 |
| Other Assets | 9,337 | 10,057 | 9,527 | 10,918 | 12,291 | 10,668 | 9,021 | 11,456 | 13,794 | 14,802 |
| Total Liabilities | 12,899 | 14,166 | 13,431 | 14,599 | 15,990 | 15,024 | 13,264 | 15,943 | 18,779 | 21,493 |
| Current Liabilities | 8,377 | 9,477 | 8,516 | 9,791 | 10,912 | 8,590 | 5,745 | 7,108 | 8,471 | 9,333 |
| Non Current Liabilities | 1,399 | 1,262 | 1,028 | 572 | 625 | 1,208 | 690 | 735 | 769 | 948 |
| Total Equity | 3,124 | 3,427 | 3,888 | 4,236 | 4,453 | 5,226 | 6,829 | 8,100 | 9,539 | 11,212 |
| Reserve & Surplus | 2,209 | 2,370 | 2,733 | 2,952 | 3,110 | 3,502 | 4,565 | 5,308 | 6,067 | 7,055 |
| Share Capital | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -227 | 23 | -21 | 314 | -375 | -65 | 625 | 47 | 661 | -265 |
| Investing Activities | -307 | -192 | -148 | 13 | -357 | -282 | -548 | -1,732 | 487 | -1,740 |
| Operating Activities | 222 | 437 | 1,969 | 259 | -52 | 1,986 | 4,771 | 2,278 | 359 | 1,972 |
| Financing Activities | -142 | -221 | -1,842 | 42 | 34 | -1,769 | -3,598 | -499 | -184 | -497 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 44.74 % | 44.74 % | 44.68 % | 44.66 % | 44.64 % | 44.61 % | 44.55 % | 44.55 % | 44.55 % | 44.51 % | 44.51 % | 42.23 % | 42.23 % | 42.23 % | 42.22 % | 41.69 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 8.71 % | 8.85 % | 10.22 % | 10.66 % | 12.64 % |
| DIIs | 2.31 % | 3.82 % | 4.23 % | 3.93 % | 4.12 % | 4.18 % | 4.23 % | 4.12 % | 4.92 % | 4.76 % | 4.22 % | 4.92 % | 11.87 % | 12.45 % | 13.29 % | 13.29 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 34.12 % | 33.05 % | 33.51 % | 33.15 % | 32.75 % | 31.69 % | 29.17 % | 29.56 % | 29.47 % | 30.26 % | 31.68 % | 33.64 % | 28.85 % | 27.11 % | 26.31 % | 25.17 % |
| Others | 18.83 % | 18.39 % | 17.58 % | 18.26 % | 18.48 % | 19.52 % | 22.05 % | 21.78 % | 21.06 % | 20.46 % | 19.59 % | 10.49 % | 8.20 % | 7.99 % | 7.52 % | 7.20 % |
| No of Share Holders | 58,101 | 68,369 | 72,531 | 69,729 | 75,303 | 76,121 | 78,194 | 82,503 | 79,937 | 88,142 | 1,07,640 | 1,08,246 | 1,07,011 | 1,18,928 | 1,26,722 | 1,26,023 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 4 | 3 | 3 | 0.00 | 0.00 | 11 | 9.5 | 4 | 0.00 |
| Dividend Yield (%) | 0.00 | 1.46 | 1.47 | 2.16 | 0.00 | 0.00 | 2.36 | 1.74 | 0.51 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
3 days ago
3 days agoShareholder Meeting / Postal Ballot-Notice of Postal Ballot4 days ago
4 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 201810 days ago
10 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 201810 days ago
10 days agoAmendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information.Mar 28, 2025
Mar 28, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 28, 2025
Mar 28, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On March 28 2025Mar 28, 2025
Mar 28, 2025Closure of Trading WindowMar 24, 2025
Mar 24, 2025Intimation Under Reg. 30(5) Of SEBI (LODR) 2015Mar 04, 2025
Mar 04, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 25, 2025
Feb 25, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 25, 2025
Feb 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2025
Feb 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2025
Feb 12, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 11, 2025
Feb 11, 2025Integrated Filing (Financial)Feb 11, 2025
Feb 11, 2025Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 11, 2025
Feb 11, 2025Board Meeting Outcome for Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 11, 2025
Feb 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2025
Feb 06, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 05, 2025
Feb 05, 2025Board Meeting Intimation for To Consider And Approve The Financial Results For The Period Ended December 31 2024Jan 29, 2025
Jan 29, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Jan 07, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 31, 2024
Dec 31, 2024Announcement Under Reg. 30 Of SEBI (LODR), 2015Dec 12, 2024
Dec 12, 2024Intimation Under Regulation 31A(8)(D) Of The SEBI (LODR), 2015Dec 12, 2024
Dec 12, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 06, 2024
Dec 06, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 04, 2024
Dec 04, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 28, 2024
Nov 28, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 27, 2024
Nov 27, 2024Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 26, 2024
Nov 26, 2024Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 26, 2024
Nov 26, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 19, 2024
Nov 19, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 15, 2024
Nov 15, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2024
Nov 15, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 15, 2024
Nov 15, 2024Announcement under Regulation 30 (LODR)-Change in ManagementNov 14, 2024
Nov 14, 2024Board Meeting Outcome for Outcome Of The Board MeetingNov 14, 2024
Nov 14, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2024
Nov 11, 2024Announcement Under Reg. 30 Of SEBI (LODR), 2015Oct 30, 2024
Oct 30, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 30, 2024
Oct 30, 2024Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For The Period Ended September 30, 2024Oct 29, 2024
Oct 29, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 18, 2024
Oct 18, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 15, 2024
Oct 15, 2024Announcement Under Regulation 30 Of SEBI (LODR), 2015Oct 11, 2024
Oct 11, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 10, 2024
Oct 10, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 08, 2024
Oct 08, 2024Closure of Trading WindowSep 25, 2024
Sep 25, 2024Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 20, 2024
Sep 20, 2024Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 28, 2024
Aug 28, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 23, 2024
Aug 23, 2024Technical Indicators
RSI(14)
Neutral 55.83
ATR(14)
Less Volatile 29.67
STOCH(9,6)
Neutral 49.99
STOCH RSI(14)
Neutral 38.14
MACD(12,26)
Bearish -0.17
ADX(14)
Weak Trend 23.04
UO(9)
Bearish 56.74
ROC(12)
Downtrend And Accelerating -0.43
WillR(14)
Neutral -27.94
About EID Parry
EID Parry (India) Limited is an Indian company established in 1900, headquartered in Chennai. It operates in sugar production, nutraceuticals, and bio pesticides. The company has 6 sugar factories with a total cane crushing capacity of 40,300 tonnes per day, 140 MW power generation capacity, and 5 distilleries producing 417 KLPD. EID Parry produces various sugar products, ethanol, and cogenerated power. Its nutraceuticals division focuses on organic products for global markets. The company has a subsidiary, Coromandel International Limited, for farm inputs business. EID Parry also produces bio pesticides, including neem extract Azadirachtins. The company serves pharmaceutical, confectionery, and food industries, selling products domestically and internationally. It has expanded into ethanol production and launched sanitizer products in response to market demands.
Website
Chairperson NameM M Venkatachalam
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
